CDT Equity Inc CDT
News
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
CDT Equity Inc. Announces Reverse Stock Split
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
